Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression

Psychological Medicine

Volumn 33, Issue 7, 2003, Pages 1277-1284

  Michael, Nikolaus ^a   Erfurth, A ^a   Ohrmann, P ^a   Arolt, V ^a   Heindel, W ^a   Pfleiderer, B ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; GLUTAMIC ACID; GLUTAMINE; LORAZEPAM; PSYCHOTROPIC AGENT;

ADULT; AGED; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CLINICAL FEATURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MEASUREMENT; MELANCHOLIA; METABOLIC DISORDER; PREFRONTAL CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE; TREATMENT OUTCOME;

AGED; BRAIN MAPPING; DEPRESSIVE DISORDER, MAJOR; DOMINANCE, CEREBRAL; ELECTROCONVULSIVE THERAPY; ENERGY METABOLISM; FEMALE; GLUTAMIC ACID; GLUTAMINE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PREFRONTAL CORTEX; REFERENCE VALUES;

EID: 0142030651     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291703007931     Document Type: Article

References (45)

1. Auer, D. P., Pütz, B., Kraft, E., Lipinski, B., Schill, J. & Holsboer, F. (2000). Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biological Psychiatry 47, 305-313.
2. Baxter, L. R., Schwartz, J. M., Phelps, M. E., Mazziotta, J. C., Guze, B. H., Selin, C. E., Gerner, R. H. & Sumida, R. M. (1989). Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archives of General Psychiatry 46, 243-250.
3. Bench, C. J., Friston, K. J., Brown, R. G., Frackowiak, R. S. J. & Dolan, R. J. (1993). Regional cerebral blood flow in depression measured by position emission tomography: the relationship with clinical dimensions. Psychological Medicine 23, 579-590.
4. Bench, C. J., Frackowiak, R. S. J. & Dolan, R. J. (1995). Changes in regional cerebral blood flow on recovery from depression. Psychological Medicine 25, 247-251.
5. Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S. & Krystal, J. H. (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry 47, 351-354.
6. Bouron, A. & Chatton, J. Y. (1999). Acute application of the tricyclic antidepressant Desipramine presynaptically stimulates the exocytosis of glutamate in the hippocampus. Neuroscience 90, 729-736.
7. 1H MRS brain measures and acute lorazepam adminisration in healthy human subjects. Neuropsychopharmacology 26, 546-551.
8. Byrum, C. E., Ahearn, E. P. & Krishnan, K. R. R. (1999). A neuro-anatomic model for depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 23, 175-193.
9. Chamberlin, E. & Tsai, G. E. (1998). A glutamatergic model of ECT-induced memory dysfunction. Harvard Reviews of Psychiatry 5, 307-317.
10. Coffey, C. E., Wilkinson, W. E., Weiner, R. D., Parashos, I. A., Djang, W. T., Webb, M. C., Figiel, G. S. & Spritzer, C. E. (1993 . Quantitative cerebral anatomy in depression. Archives of General Psychiatry, 50, 7-16.
11. Cummings, J. L. (1995). Anatomic and behavioral aspects of frontal-subcortical circuits. Annals of the New York Academy of Science 769, 1-13.
12. Frahm, J., Bruhn, H., Gyngell, M. L., Merboldt, K. D., Hänicke, W. & Sauter, R. (1989). Localized high-resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo. Magnetic Resonance in Medicine 9, 79-93.
13. Fuster, J. M. (1997). Transmitters in the prefrontal cortex. In Prefrontal Cortex, 3rd edn. (ed. J. M. Fuster), pp. 45-60. Lippincott-Raven: Philadelphia.
14. George, M. S., Ketter, T. A. & Post, R. M. (1994). Prefrontal cortex dysfunction in clinical depression. Depression 2, 59-72.
15. Goodwin, G. M. (1997). Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. Journal of Psychopharmacology, 11, 115-122.
16. Hamakawa, H., Kato, T., Shioiri, T., Inubushi, T. & Kato, N. (1999). Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder. Psychological Medicine 29, 639-644.
17. Hiller, W., Zaudig, M. & Mombour, W. (2000). Internationale Diagnosen Checklisten (IDCL) DSM-IV. Hogrefe Verlag: Göttingen.
18. 31P-MRS. Psychological Medicine 25, 557-566.
19. Kennedy, S. H., Evans, K. R., Krüger, S., Mayberg, H. S., Meyer, J. H., McCann, S., Arifuzzman, A. I., Houle, S. & Vaccarino, F. J. (2001). Changes in regional brain glucose metabolism measured with positron emission tomography after paroextin treatment of major depression. American Journal of Psychiatry 158, 899-905.
20. Ketter, T. A., Kimbrell, T. A., George, M. S., Dunn, R. T., Speer, A. M., Benson, B. E., Willis, M. W., Danielson, A., Frye, M. A., Herscovitch, P. & Post, R. M. (2001). Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biological Psychiatry 49, 97-109.
21. Knable, M. B., Barci, B. M., Bartko, J. J., Webster, M. J. & Torrey, E. F. (2002). Molecular abnormalities in the major psychiatric illnesses: classification and regression tree (CRT) analysis of post-mortem prefrontal markers. Molecular Psychiatry 7, 392-404.
22. Kumar, A., Schweizer, E., Zhisong, J., Miller, D., Bilker, W., Swan, L. L. & Gottlieb, G. (1997). Neuroanatomical substrates of late-life minor depression. Archives of Neurology 54, 613-617.
23. Kumar, A., Bilker, W., Zhisong, J. & Udupa, J. (2000). Atrophy and high intensity lesions: complementary neurobiological mechanisms in late-life major depression. Neuropsychopharmacology 22, 264-274.
24. Mayberg, H. S., Liotti, M., Brannan, S. K., McGinnis, S., Mahurin, R. K., Jerabek, P. A., Silva, J. A., Tekell, J. L., Martin, C. C., Lancaster, J. L. & Fox, P. T. (1999). Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. American Journal of Psychiatry 156, 675-682.
25. Mayberg, H. S., Brannan, S. K., Tekell, J. L., Silva, J. A., Mahurin, R. K., McGinnis, S. & Jerabek, P. A. (2000). Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biological Psychiatry 48, 830-843.
26. Michaelis, T., Merboldt, K. D., Bruhn, H., Hänicke, W. & Frahm, J. (1993). Absolute concentration of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 187, 219-227.
27. Moghaddam, B., Adams, B., Verma, A. & Daly, D. (1997). Activation of glutamatergic, neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with prefrontal cortex. Journal of Neuroscience 17, 2921-2927.
28. Nolan, C. L., Moore, G. J., Madden, R. T. F., Bartoi, M., Lorch, E., Stewart, C. M. & Rosenberg, D. R. (2002). Prefrontal cortical volume in childhood-onset major depression. Archives of General Psychiatry 59, 173-179.
29. Pfleiderer, B., Michael, N., Erfurth, A., Ohrmann, P., Homann, U., Wolgast, M., Fiebich, M., Arolt, V. & Heindel, W. (2003). Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatric Research Neuroimaging 122, 185-192.
30. Provencher, S. W. (1993). Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine 30, 672-679.
31. Prudic, J., Haskett, R. F., Mulsant, B., Malone, K. M., Pettinati, H. M., Stephens, S., Greenberg, R., Rifas, S. L. & Sackheim, H. A. (1996). Resistance to antidepressant medications and short-term clinical response to ECT. American Journal of Psychiatry 153, 985-992.
32. Rajkowska, G. (1997). Morphometric methods for studying the prefrontal cortex in suicide victims and psychiatric patients. Annals of the New York Academy of Sciences 836, 253-268.
33. Rajkowska, G. (2000). Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biological Psychiatry 48, 766-777.
34. Rajkowska, G. & Goldman-Rakic, P. S. (1995). Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of area 9 and 46 and relationship to the Talairach coordinate system. Cerebral Cortex 45, 323-337.
35. Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L. & Stockmeier, C. A. (1999). Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry 45, 1085-1098.
36. Rajkowska, G., Halaris, A. & Selemon, L. D. (2001). Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biological Psychiatry 49, 741-752.
37. Rothman, D. L., Hyder, F., Sibson, N., Behar, K. L., Mason, G. F., Shen, J., Petroff, O. A. C. & Shulman, R. G. (2002). In vivo magnetic resonance spectroscopy studies of the glutamate and GABA neurotransmitter cycles and functional neuroenergetics. In Neuropsychopharmacology: The Fifth Generation of Progress (ed. K. L. Davis, D. Charney, J. T. Coyle and C. Nemeroff), pp. 316-342. Lippincott, Williams & Wilkins: Philadelphia.
38. 1H-MRS and un-biased stereology: can non-invasive measures of N-acetyl-aspartate following global ischemia be used as a reliable measure of neuronal damage? Brain Research 892, 166-175.
39. Sheline, Y. I. & Mintun, M. A. (2002). Structural and functional imaging of affective disorders. In Neuropsychopharmacology: The Fifth Generation of Progress (ed. K. L. Davis, D. Charney, J. T. Coyle and C. Nemeroff), pp. 1065-1079. Lippincott, Williams & Wilkins: Philadelphia.
40. Silbersweig, D. A. & Stern, E. (1997). Symptom localization in neuropsychiatry. Annals of the New York Academy of Sciences 835, 410-420.
41. Soares, J. C., Krishnan, K. R. & Keshavan, M. S. (1996). Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders. Depression 4, 14-30.
42. Tsai, G. & Coyle, J. T. (1995). N-acetyl-aspartate in neuropsychiatric disorders. Progress in Neurobiology 46, 531-540.
43. Tsai, G., Passani, L. A., Slusher, B. S., Carter, R., Kleinman, J. E. & Coyle, J. T. (1995). Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Archives of General Psychiatry 52, 829-836.
44. 1H magnetic resonance spectroscopy. Magnetic Resonance in Medicine 39, 28-33.
45. Winsberg, M. E., Sachs, N., Tate, D. L., Adalsteinsson, E., Spielman, D. & Ketter, T. A. (2000). Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biological Psychiatry 47, 475-481.